等待开盘 12-20 09:30:00 美东时间
+0.803
+2.32%
今日重点评级关注:Stifel:维持X4 Pharmaceuticals"买入"评级,目标价从7.5美元升至10美元;花旗:维持UP Fintech Holding"买入"评级,目标价从17.4美元升至17.5美元
12-08 08:34
BWS Financial analyst Hamed Khorsand maintains TriMas (NASDAQ:TRS) with a Buy and maintains $45 price target.
12-06 02:58
TriMas (NASDAQ:TRS) today announced the appointment of Paul Swart as Chief Financial Officer, effective December 15, 2025. Paul will report to Thomas Snyder, TriMas President and Chief Executive Officer, and will succeed
12-05 02:05
The most oversold stocks in the materials sector presents an opportunity to buy...
11-21 19:34
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
Keybanc analyst Ken Newman maintains TriMas (NASDAQ:TRS) with a Overweight and lowers the price target from $45 to $38.
11-13 21:42
TriMas (TRS) said Tuesday it agreed to sell its aerospace segment for $1.45 billion in cash to an affiliate of Tinicum, with Blackstone (BX) taking a minority stake in the deal, marking the latest in ...
11-04 22:57
TriMas (NASDAQ:TRS) announced today that it has entered into a definitive agreement to sell its Aerospace segment for an all-cash purchase price of approximately $1.45 billion to an affiliate of Tinicum L.P. (the
11-04 21:46
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
BWS Financial analyst Hamed Khorsand maintains TriMas (NASDAQ:TRS) with a Buy and maintains $45 price target.
11-01 01:58